ClearPoint Neuro (CLPT)
(Delayed Data from NSDQ)
$12.89 USD
+0.50 (4.04%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $12.86 -0.03 (-0.23%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth A Momentum C VGM
View All Zacks #1 Ranked Stocks
ClearPoint Neuro, Inc. (CLPT) Price Targets
| Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
|---|---|---|---|
| $13.00 | $15.00 | $10.00 | 4.92% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for ClearPoint Neuro, Inc. comes to $13.00. The forecasts range from a low of $10.00 to a high of $15.00. The average price target represents an increase of 4.92% from the last closing price of $12.39.
Analyst Price Targets (3 )
Broker Rating
ClearPoint Neuro, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, three are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
| Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
| Date | Brokerage Firm | Analyst | Previous | Current |
|---|---|---|---|---|
| 8/7/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
| 8/5/2024 | Lake Street Capital Markets | Frank Takkinen | Strong Buy | Strong Buy |
| 7/25/2024 | B. Riley Securities | Kyle Bauser | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
| Current ABR | 1.00 |
| ABR (Last week) | 1.00 |
| # of Recs in ABR | 3 |
| Average Target Price | $13.00 |
| LT Growth Rate | NA |
| Industry | Medical - Instruments |
| Industry Rank by ABR | 79 of 252 |
| Current Quarter EPS Est: | -0.17 |
CLPT FAQs
ClearPoint Neuro, Inc. (CLPT) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 3 brokerage firms.
The average price target for ClearPoint Neuro, Inc. (CLPT) is $13.00. The current on short-term price targets is based on 2 reports.
The forecasts for ClearPoint Neuro, Inc. (CLPT) range from a low of $10 to a high of $15. The average price target represents a increase of $0.85 from the last closing price of $12.89.
The current UPSIDE for ClearPoint Neuro, Inc. (CLPT) is 0.85%
Based on short-term price targets offered by three analysts, the average price target for ClearPoint Neuro, Inc. comes to $13.00. The forecasts range from a low of $10.00 to a high of $15.00. The average price target represents an increase of 4.92% from the last closing price of $12.39.